Cell-free protein synthesis by reticulocyte lysates was inhibited by a polyadenylated RNA fraction extracted from HeLa cells infected with vesicular stomatitis virus (VSV) but not by polyadenylated RNA from mock-infected HeLa cells. A similar inhibitor of cell-free protein synthesis was found in a polyadenylated fraction of RNA transcribed in vitro by VSV but not in untranscribed nucleocapsids. Fractionation of the VSV transcription product showed that the translation inhibitor segregated with nucleocapsids containing newly transcribed polyadenylated or non-polyadenylated RNA, as determined by oligodeoxythymidylatecellulose chromatography. The inhibitors present in VSV-infected HeLa cells and in VSV in vitro transcripts both appeared to be double-stranded RNA, as judged by the characteristics for inhibition of reticulocyte cell-free protein synthesis described by Hunter et al. (J. Biol. Chem. 250:409-417, 1975). The doublestranded nature of the VSV RNA inhibitor was supported by the finding that the translational inhibitory effect was inactivated by melting the inhibitor in the absence of salt and by micrococcal nuclease.
Infection with wild-type vesicular stomatitis virus (VSV) results in rapid inhibition of cellular protein synthesis, a genetically determined event that requires functional viral transcription (18) . This inhibitory effect appears to be directed at the initiation of translation (23) , but the underlying mechanism is not understood. It has been clearly shown, however, that double-stranded RNA (dsRNA), natural or synthetic, can serve as a potent inhibitor of protein synthesis in various in vitro translation systems derived from mammalian cells (10, 15, 28) . Protein synthesis in reticulocyte lysates is inhibited by dsRNA, which activates a protein kinase which phosphorylates the small subunit of eucaryotic initiation factor 2 (12) . In addition, dsRNA has been shown to be capable of inducing interferon (7) and activating interferon-induced enzymes which, in turn, inactivate eucaryotic initiation factor 2 and activate an endonuclease and perhaps other enzymes which inhibit protein synthesis (3, 21, 27) .
Viral dsRNA may play a role in the inhibition of protein synthesis in cells infected with certain viruses. The presence of dsRNA has been detected in cross-linking studies in HeLa cells infected with encephalomyocarditis virus or the tsG114 mutant of VSV (22) . mRNA prepared from reovirus transcribed in vitro and polyadenylated [poly(A)+] RNA from vaccinia virus transcribed in vitro have been shown to contain dsRNA which also inhibits protein synthesis in cell-free systems (1, 19) .
We report here the presence in VSV-infected HeLa cells but not in uninfected cells of an inhibitor of cell-free protein synthesis which behaves like dsRNA. We also found a similar dsRNA inhibitor of protein synthesis after in vitro VSV transcription of poly(A)+ and poly(A)-RNA associated with viral nucleocapsids.
MATERIALS AND METHODS
Cell cultures and viruses. The wild-type San Juan strain of the Indiana serotype of VSV was originally obtained from the U.S. Agriculture Research Center, Beltsville, Md. (29) .
BHK-21 cells were cultivated as previously described (2) . VSV was grown in BHK-21 cells as outlined previously (9) . HeLa S3 cells were grown in suspension cultures in Joklik modified minimum essential medium (MEM) with glutamine (2 mM) and 10% calf serum.
Chemicals and radioisotopes. Rabbit globin mRNA was purchased from Bethesda Research Laboratories, Rockville, Md., and polyinosinate-polycytidylate [poly(I):poly(C)] was purchased from Miles Biochemicals, Elkhart, Ind.
[IS]methionine (1,174.9 Ci/mmol), suspension cultures were grown to a density of 4 x 105 cells per ml and harvested by low-speed centrifugation. Cells were then suspended in 200 ml of MEM and divided into two equal portions. One portion was mock infected with MEM, and the other was infected with VSV suspended in MEM at a multiplicity of infection of 10. After adsorption of the inoculum for 30 min at room temperature, each portion was diluted to a total volume of 1 liter with MEM. At 2.5 h postinfection (p.i.), [3H] uridine was added to each culture to a concentration of 5 ,uCi/ml. At 4.5 h p.i., both cultures were harvested by low-speed centrifugation, washed in phosphate-buffered saline, and subjected to detergent-phenol-chloroform extraction as described by Palmiter (24) . After ethanol precipitation at -20°C overnight, each RNA preparation was subjected to oligodeoxythymidylate (oligo-dT)-cellulose chromatography, a second ethanol precipitation as described above, and another pass over oligo-dT-cellulose. The poly(A)+ RNA was recovered by ethanol precipitation and suspended in sterile water, and absorption readings were determined at wavelengths of 260 and 280 nm.
In vitro translation reactions. Micrococcal nucleasetreated rabbit reticulocyte lysate was purchased from Amersham/Searle Corp., Arlington Heights, Ill., and translation reactions were performed in reaction mixtures essentially as described by Pelham and Jackson (25) . Unless otherwise noted, translation reactions were run with K+ concentrations of 133 mM and Mg2" concentrations of 1.83 mM.
The in vitro translation reaction mixtures were incubated at 31°C for the times indicated in a total reaction volume of 25 pul. In addition to the reticulocyte lysate, the following preparations to be tested for their effect on translation were prepared by being lyophilized under nitrogen gas: mixtures of either 3H-amino acids at 0.6 ,uCi/,ul or [35S]methionine at 1 ,uCi/ pul and poly(A)+ RNA from either mock-or VSVinfected cells or various fractions of RNA made in vitro during a VSV transcription reaction. Also present, where indicated, were lyophilized rabbit globin mRNA and poly(I):poly(C). Reactions were then initiated by adding 25 ,ul of micrococcal nuclease-treated reticulocyte lysate which had been previously combined with the reaction mix by the method described by Pelham and Jackson (25) . The lysate also contained hemin, 0.02 mM; creatine phosphate, 10 mM; creatine kinase, 50 ,ug/ml; Ca2", 1 In vitro transcription by VSV. The Indiana serotype of VSV was cultivated and purified from BHK-21 cells as previously described (9) , and the protein concentration was determined by the method of Lowry et al. (17) . As previously described (4) , purified VSV at a protein concentration of 2.0 mg/ml in reticulocyte standard buffer, pH 8.0, with 15% glycerol was solubilized for 3 min at 4°C with an equal volume of Tritonhigh salt solubilizer consisting of Triton X-100, 4%; glycerol, 15%; NaCl, 1.4 M; dithiothreitol, 7.4 mM; and reticulocyte standard buffer (pH 8.0), 50%. To this mixture was then added 5 volumes of prereaction mixture consisting of 2.0 mM each of ATP, GTP, and CTP, 0.2 mM of [3H]UTP (244 mCi/mM), and 15% reticulocyte standard buffer-30% glycerol (pH 8.0). Transcription was then initiated by the addition of 3 volumes of 0.1 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) buffer (pH 8.0) containing 16 mM magnesium acetate. The reaction mixtures were incubated for 3 h at 31°C, and the RNA was then extracted with phenol-chloroform and precipitated with ethanol. Where noted, the transcription reactions were centrifuged for 2 h at 4°C in a Beckman SW50.1 rotor at 48,000 rpm to remove the nucleocapsids before phenol-chloroform extraction of the RNA. The nucleocapsid pellet was recovered by suspension in 0.01 M Tris (pH 7.4), and RNA from both the supernatant and the nucleocapsid was phenol-chloroform extracted and ethanol precipitated.
RESULTS
Comparative translational inhibitory effects of poly(A)+ RNA extracted from VSV-infected or uninfected HeLa cells. The [35S]methionine ( (Fig. 2) . When similarly low levels of exogenous globin mRNA only were added to reticulocyte lysates, the translational activity was reduced by an equivalent 15% (data not shown). Apparently, this translational system is susceptible to inhibition by low levels of nonspecific exogenous poly(A)+ RNA.
A more severe reduction (up to 55%) occurred in [35S]methionine incorporation by reticulocyte lysates exposed to higher concentrations (0.1 to 1.0 ,ug/ml) of poly(A)+ RNA from VSV-infected cells (Fig. 2) . By comparison, equivalent amounts of exogenous poly(A)+ RNA from mock-infected cells caused only a limited reduction in protein synthesis. Apparently, exogenous RNA in general slightly depresses the translation of endogenous reticulocyte messengers, but VSV poly(A)+ RNA has a more pronounced effect on the protein synthesizing machinery of reticulocyte lysates. Larger concentrations (50 ,ug/ml) of poly(A)+ RNA from VSV-infected cells resulted in greater synthesis of specific VSV proteins (data not shown) but also reversed the inhibitory effect on endogenous protein synthesis, as was expected for a preparation containing dsRNA.
The effect of poly(A)+ RNA from mock-and VSV-infected HeLa cells on protein synthesis by reticulocyte lysates primed with 0.5 ,ug of (Fig. 3) . Thereafter, there was a d HeLa cells in the presence of exogenous marked decline in, followed by cessation of, mRNA (0.5 ,ug/ml).
protein synthesis in reticulocyte lysates containing VSV-infected cell RNA but not in those containing mock-infected cell RNA.
Since the kinetics of protein synthesis inhibinous globin mRNA per ml was also deter-tion by poly(A)+ RNA from VSV-infected cells (Fig. 2) . Under these conditions, low resembled that previously reported for protein ntrations (0.001 to 0.05 pug/ml) of poly(A)+ synthesis inhibition by dsRNA (13), we tested from either mock-or VSV-infected cells the effect of poly(I):poly(C) on the reticulocyte o effect on reticulocyte lysate translation. lysate. Poly(I):poly(C) at the same concentrat, higher concentrations of poly(A)+ RNA tion (0.5 ,g/ml) which had been found to be nock-infected HeLa cells (0.1 to 1.0 jig/ml) optimal for inhibiting translation had an almost ot impair in vitro translation of globin identical effect on protein synthesis as did A. In sharp contrast, concentrations of poly(A)+ RNA from VSV-infected cells.
W RNA from VSV-infected cells at levels If inhibition of protein synthesis caused by ).1 jig/ml markedly reduced [35S]methion-VSV-infected cell RNA is due to the presence of corporation in the globin mRNA-primed dsRNA, then very high concentrations of a ilocyte lysates. Similar results were synthetic dsRNA such as poly(I):poly(C) should ned when 3H-amino acid instead of reverse the inhibitory effect, as was reported by iethionine incorporation was used to mea-Hunter et al. (13) . High concentrations (50 ,ug/ )rotein synthesis (data not shown). Poly-ml) of poly(I):poly(C) were effective in reversing imide gel electrophoresis of [35S]methio-the inhibition of protein synthesis produced by abeled proteins synthesized under these poly(A)+ RNA from VSV-infected cells (Fig. 3) .
:ions revealed proportionate reductions in Moreover, poly(I):poly(C) at a concentration of J. VIROL. 50 ,ug/ml had no effect on the translation reaction containing poly(A)+ RNA from mock-infected HeLa cells.
These studies suggest that the protein synthesis-inhibitory factor in poly(A)+ RNA from VSV-infected cells is dsRNA or behaves like dsRNA, unlike the poly(A)+ RNA from uninfected cells.
Evidence that the protein synthesis inhibitor in VSV-infected cells is dsRNA. To test the hypothesis that the protein synthesis inhibitor is dsRNA, we tested the susceptibility of the inhibitory poly(A)+ RNA from VSV-infected HeLa cells to melting, micrococcal nuclease, and the K+ optima. Heating the RNA to 100°C and cooling it quickly in HEPES-KOH buffer abolished the capacity of infected-cell poly(A)+ RNA to inhibit protein synthesis in a reticulocyte lysate, whereas heating and cooling it under reannealing conditions in 0.3 M NaCl had no effect on its inhibitory properties (Table 1) . Similar treatment did not affect the inactive poly(A)+ RNA from mock-infected cells, but the capacity of poly(I):poly(C) to inhibit protein synthesis was similarly abolished by melting it at 100°C and cooling it quickly in HEPES buffer. It seems likely, therefore, that double-strandedness or significant secondary structure are as essential for the inhibitory effect of VSV-infected cell poly(A)+ RNA on in vitro protein synthesis as they are for the effect of poly(I):poly(C).
Micrococcal nuclease is capable of digesting double-stranded nucleic acids (10) . Therefore, we tested this enzyme by the procedure of Pelham and Jackson (25) for nuclease treatment centration for optimal [35S]methionine incorporation to about 205 mM, as compared with the 100 to 150 mM K+ concentration which was optimal for translation in the presence of equivalent concentrations of exogenous globin mRNA or poly(A)+ RNA from mock-infected HeLa cells (Fig. 4) . Moreover, whereas inhibition by VSV-infected cell poly(A)+ RNA was abolished by the presence of 50 jig of poly(I):poly(C) per ml, the K+ concentration for optimal translation reverted to -133 mM (Fig. 4) poly(C) per ml abolished their ability to inhibit protein synthesis by reticulocyte lysates reconstituted with exogenous globin mRNA. Micrococcal nuclease had little or no effect on poly(A)+ RNA controls from mock-infected HeLa cells (Table 1 ). The effects of melting and micrococcal nuclease treatment indicate that double-strandedness may be the critical property of infected-cell poly(A)+ RNA that enables it to inhibit protein synthesis. Another property of dsRNA is its ability to shift the optimum concentrations of potassium required for translation of vaccinia virus transcripts in the reticulocyte lysate translation system (1). Baglioni et al. (1) reported that the optimum concentration of salt for the translation of vaccinia virus mRNA is influenced by the presence of a dsRNA inhibitor which copurifies with vaccinia virus poly(A)+ RNA. Therefore, we chose to examine the K+ concentration required for optimal reticulocyte lysate translation under conditions of dsRNA inhibition or no inhibition. Poly(I): poly(C) or VSV-infected cell poly(A)+ RNA (0.5 ,ug/ml) shifted the K+ con- K+ concentrations, specific VSV I and M became more visible (Fig. 5 tein N was obscured by the actin ban proteins G and L could not be dete data also demonstrate the presence RNA from infected cells of intact N not greatly degraded in these prepa:
These data on the K+ optima of are consistent with the hypothesis th lation inhibitor in VSV-infected ce RNA is dsRNA.
Translation proteins NS inhibit protein synthesis by.reticulocyte lysates.
). VSV pro-Standard procedures for in vitro transcription by id, and VSV purified VS virions were used to produce RNA cted. These transcripts (4), which were then separated in poly(A)+ by oligo-dT-cellulose chromatography into viral mRNA poly(A)+ and poly(A)-RNA as described rations.
above. These in vitro-produced VSV transcripts F translation contained viral mRNA that could be translated rat the trans-in reticulocyte lysates; as expected, the major 11 poly(A)+ VSV proteins synthesized were N, NS, and M (data not shown). by in vitro Figure 6 shows the effects of increasing conregoing evi-centrations of various RNA fractions isolated in synthesis from the VS virion transcription reaction on uninfected protein synthesis by micrococcal nuclease-treatproduct or a ed reticulocyte lysates supplemented with exogtranslation enous globin mRNA. As noted, [35S]methionine product was incorporation was inhibited 40 to 45% by by cell-free poly(A)+ RNA (0.5 ,ug/ml or greater concentras ability to tions) isolated by nhenol-chloroform extraction of complete VS virion transcription reactions from which nucleocapsids had not been removed. In contrast, when transcribed nucleocapsids were removed by centrifugation, equivalent concentrations of supernatant poly(A)+ -RNA had no effect on reticulocyte translation.
The RNA pelleting with virion nucleocapsids after a 60-min transcription, or mock transcription in the absence of nucleoside triphosphates, was extracted with phenol-chloroform and tested for its effect on reticulocyte lysate translation. Protein synthesis was inhibited by RNA extracted from newly transcribed nucleocapsids at concentrations of 0.05 ,ug/ml or greater but 10°1< 1 not by untranscribed template RNA at any concentration (Fig. 6 ). These data indicate that RNA newly transcribed from virion nucleocapsids inhibits protein synthesis only in association fractions ex-with virion template RNA, which itself is not S virions on inhibitory. (Fig. 7) . In fact, it appears that the po-)ly(A)+ RNA ly(A)-RNA from newly transcribed nucleocap-:s (not centri-sids was more inhibitory at lower concentrations 1, poly(A)+ than was the poly(A)+ RNA. s relationship, we tested the protein synthesis RNA extracted from transcribed nucleocapsids, iibitor in VS virion transcripts for its suscepti-to levels of -40 to 50% inhibition of translation ity to poly(I):poly(C), melting, micrococcal by 40 min. In each case, including the control, ,lease, and shifts in K+ concentration in poly(I):poly(C) reversed the inhibitory effect of )eriments similar to those reported above for the poly(A)+ and poly(A)-RNA extracted from VSV-infected cell inhibitor. transcribed nucleocapsids (data not shown). The Phe kinetics of protein synthesis inhibition in kinetics of the translation-inhibitory effects of reticulocyte lysate system were examined in poly(A)+ and poly(A) RNA from VS virion presence of poly(A)+ or poly(A) RNA nucleocapsid transcripts and the reversal by :racted from VS virion nucleocapsids that had poly(I):poly(C) were similar to the data for VSVlergone transcription at 31°C for 60 min. infected cell RNA (Fig. 3) and provide further ntrols contained only exogenous globin evidence for the dsRNA nature of these transla-LNA and, as described in the legend to Fig. 3 , tion inhibitors present in association with tranntical duplicate translation reactions were scribed nucleocapsids.
in the presence of 50 ,ug of poly(I):poly(C)
In experiments similar to those for VSVml. The results were essentially the same as infected cell RNA (Table 1) , we found that the )se reported in Fig. 3 ,ug/ml with the poly(A)+ and poly(A)-RNA inhibitors, the K+ optima for reticulocyte lysate translation reverted to 140 to 150 mM. Once again, these data are consistent with previously reported studies (1) on K+ optima for globin mRNA translation and reinforce the postulate that the inhibitory factor(s) behaves like dsRNA probably derived from VSV transcripts basepaired with nucleocapsid RNA.
DISCUSSION
In vitro translation by rabbit reticulocyte lysates is sensitive to inhibition by dsRNA (10, 13) . Typically, inhibition by dsRNA occurs abruptly but only after a lag period of 10 to 15 min, before which time protein synthesis occurs at control rates. This inhibition of protein synthesis is associated with the disappearance of detectable met-tRNAf-40S ribosomal subunit complexes (8) . The addition of eucaryotic initiation factor 2, which under control conditions promotes the binding of met-tRNAf to the 40S ribosomal subunit, can reverse dsRNA inhibition of protein synthesis (6, 14, 15 ). An inhibitor activated by dsRNA has been shown to be present in reticulocyte lysates and to have protein kinase activity that is highly selective for the small subunit of eucaryotic initiation factor 2 (11). In addition to its biphasic kinetics, inhibition of protein synthesis in these systems occurs over a limited dsRNA concentration range and can readily be reversed by the addition of high concentrations (>10 ,ug/ml) of either naturally occurring or synthetic dsRNA (13) . Other cellfree protein synthesizing systems have been shown to be susceptible to inhibition by dsRNA, but these systems do not appear to be as sensitive to dsRNA as the rabbit reticulocyte system is (12, 28) .
Several groups have also reported inhibition of cell-free translation by viral dsRNA. The replicative intermediate of poliovirus has been shown to inhibit translation in cell-free systems derived from HeLa cells (5) and rabbit reticulocytes (10) . In addition, there are reports of dsRNA inhibitory activity associated with mRNA preparations. dsRNA inhibitory activity has been reported to be present in preparations of poly(A)+ RNA transcribed in vitro by vaccinia virus and purified by oligo-dT-cellulose chromatography (1) . Such activity has also been observed in reovirus mRNA preparations transcribed in vitro (1, 19) . It should be noted that poly(A)+ RNA isolated from the cytoplasm of normal uninfected BSC-1 cells also induces a dsRNA-activated protein kinase in a cell-free translation system derived from interferon-treated BSC-1 cells, but with an efficiency about 1% that of pure dsRNA such as poly(I):poly(C) (26) . Whether the inhibitory activity present in these mRNA preparations is due to the presence of contaminating non-mRNA dsRNA or the presence of mRNAs with sufficient dsRNA character to activate the protein kinase is not clear.
We report here that VSV-infected HeLa cells, when subjected to detergent-phenol-chloroform extraction, yield an inhibitor of cell-free protein synthesis that copurifies with poly(A)+ RNA. A similar RNA inhibitor was found after in vitro transcription of purified virions. The VSV RNA inhibitors described here display the following characteristics previously described by Hunter et al. (13) for dsRNA inhibitors of protein synthesis: (i) the inhibitor is effective only over a limited concentration range; (ii) inhibition occurs only after a lag period of 10 to 15 min; (iii) the inhibition can be reversed by high concentrations of a synthetic dsRNA such as poly(I): poly(C).
In addition, we have demonstrated that the VSV inhibitors of protein synthesis are inactivated by melting at 100°C and by the addition of micrococcal nuclease. Baglioni et al. (1) were able to show that the K+ optimum for protein synthesis in reticulocyte lysates is shifted upward by the presence of a dsRNA inhibitor. We also observed similar K+ optima with the inhibitors isolated from VSV-infected HeLa cells and VSV transcription reactions. Moreover, we noted that the shift to a higher K+ optimum in the presence of either inhibitor could be reversed by high concentrations of poly(I):poly(C). Moyer and Banejee (20) previously reported the formation of double-stranded transcriptive intermediates after in vitro VSV transcription reactions. They estimated that 41% of the product transcribed in vitro remained in the form of such transcriptive intermediates after transcription in vitro for 2 h. We estimate that as much as 25 to 30% of the transcribed product pellets with the nucleocapsid template after VS virion transcription; analysis of this pelleted RNA before phenol extraction by electrophoresis under nondenaturing conditions in 0.7% agarose indicates that a majority of the 32P-labeled product runs with the unlabeled template. These results are further evidence for the presence of dsRNA transcriptive intermediates in VSV transcription reactions. Based on these observations, we propose that the inhibitors that copurify with poly(A)+ RNA from VSV-infected HeLa cells and VSV transcription reactions are dsRNAs.
The presence of dsRNA inhibitors in poly(A)+ RNA preparations has been reported for other systems (1) . At present we are unable to state unequivocally that the in vivo-produced inhibitor reported here is a viral product rather than a cellular product induced by viral infection. However, the presence of a similar inhibitor after transcription in vitro of VS virions free of cellular material supports the evidence that viral RNA is the inhibitor of protein synthesis.
